Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Mol Cell Biochem ; 400(1-2): 29-40, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25348362

ABSTRACT

There is a growing body of evidence supporting an intimate association of immune activation with the pathogenesis of cardiovascular diseases, including atherosclerosis. Uptake of oxidized low-density lipoprotein (oxLDL) through scavenging receptors promotes the formation of mature lipid-laden macrophages, which subsequently leads to exacerbation of regional inflammation and atherosclerotic plaque formation. In this study, we first examined changes in the mRNA level of the lectin-like oxLDL receptor-1 (LOX-1) in the mouse macrophage cell line RAW264.7 and the human PMA-induced macrophage cell line THP-1 after LPS stimulation. LPS significantly up-regulated LOX-1 mRNA in RAW264.7 cells; LOX-1 cell-surface protein expression was also increased. Flow cytometry and fluorescence microscopy analyses showed that cellular uptake of fluorescence (Dil)-labeled oxLDL was significantly augmented with LPS stimulation. The augmented uptake of Dil-oxLDL was almost completely abrogated by treatment with an anti-LOX-1 antibody. Of note, knockdown of Erk1/2 resulted in a significant reduction of LPS-induced LOX-1 up-regulation. Treatment with U0126, a specific inhibitor of MEK, significantly suppressed LPS-induced expression of LOX-1 at both the mRNA and protein levels. Furthermore, LOX-1 promoter activity was significantly augmented by LPS stimulation; this augmentation was prevented by U0126 treatment. Similar results were also observed in human PMA-induced THP-1 macrophages. Taken together, our results indicate that LPS up-regulates LOX-1, at least in part through activation of the Erk1/2 signaling pathway, followed by augmented cellular oxLDL uptake, thus highlighting a critical role of TLR4-mediated aberrant LOX-1 signaling in the pathogenesis of atherosclerosis.


Subject(s)
Atherosclerosis/genetics , Inflammation/genetics , Plaque, Atherosclerotic/genetics , Scavenger Receptors, Class E/biosynthesis , Animals , Atherosclerosis/pathology , Gene Expression Regulation/drug effects , Humans , Inflammation/pathology , Lipopolysaccharides/administration & dosage , Lipoproteins, LDL/genetics , Lipoproteins, LDL/metabolism , MAP Kinase Signaling System/drug effects , Macrophages/metabolism , Macrophages/pathology , Mice , Plaque, Atherosclerotic/pathology , RNA, Messenger/biosynthesis , Scavenger Receptors, Class E/genetics , Signal Transduction/drug effects , Toll-Like Receptor 4/biosynthesis
2.
BMC Infect Dis ; 14: 392, 2014 Jul 15.
Article in English | MEDLINE | ID: mdl-25022982

ABSTRACT

BACKGROUND: Although endemic cholera causes significant morbidity and mortality each year in Nepal, lack of information about the causal bacterium often hinders cholera intervention and prevention. In 2012, diarrheal outbreaks affected three districts of Nepal with confirmed cases of mortality. This study was designed to understand the drug response patterns, source, and transmission of Vibrio cholerae associated with 2012 cholera outbreaks in Nepal. METHODS: V. cholerae (n = 28) isolated from 2012 diarrhea outbreaks {n = 22; Kathmandu (n = 12), Doti (n = 9), Bajhang (n = 1)}, and surface water (n = 6; Kathmandu) were tested for antimicrobial response. Virulence properties and DNA fingerprinting of the strains were determined by multi-locus genetic screening employing polymerase chain reaction, DNA sequencing, and pulsed-field gel electrophoresis (PFGE). RESULTS: All V. cholerae strains isolated from patients and surface water were confirmed to be toxigenic, belonging to serogroup O1, Ogawa serotype, biotype El Tor, and possessed classical biotype cholera toxin (CTX). Double-mismatch amplification mutation assay (DMAMA)-PCR revealed the V. cholerae strains to possess the B-7 allele of ctx subunit B. DNA sequencing of tcpA revealed a point mutation at amino acid position 64 (N → S) while the ctxAB promoter revealed four copies of the tandem heptamer repeat sequence 5'-TTTTGAT-3'. V. cholerae possessed all the ORFs of the Vibrio seventh pandemic island (VSP)-I but lacked the ORFs 498-511 of VSP-II. All strains were multidrug resistant with resistance to trimethoprim-sulfamethoxazole (SXT), nalidixic acid (NA), and streptomycin (S); all carried the SXT genetic element. DNA sequencing and deduced amino acid sequence of gyrA and parC of the NAR strains (n = 4) revealed point mutations at amino acid positions 83 (S → I), and 85 (S → L), respectively. Similar PFGE (NotI) pattern revealed the Nepalese V. cholerae to be clonal, and related closely with V. cholerae associated with cholera in Bangladesh and Haiti. CONCLUSIONS: In 2012, diarrhea outbreaks in three districts of Nepal were due to transmission of multidrug resistant V. cholerae El Tor possessing cholera toxin (ctx) B-7 allele, which is clonal and related closely with V. cholerae associated with cholera in Bangladesh and Haiti.


Subject(s)
Cholera/epidemiology , Disease Outbreaks , Drug Resistance, Multiple, Bacterial , Vibrio cholerae O1/drug effects , Anti-Bacterial Agents/pharmacology , DNA Fingerprinting , Diarrhea/epidemiology , Electrophoresis, Gel, Pulsed-Field , Humans , Nepal/epidemiology , Open Reading Frames , Phenotype , Polymerase Chain Reaction , Sequence Analysis, DNA , Vibrio cholerae O1/pathogenicity , Virulence
4.
J Med Microbiol ; 62(Pt 4): 599-609, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23319310

ABSTRACT

Cholera, caused by Vibrio cholerae, results in significant morbidity and mortality worldwide, including Thailand. Representative V. cholerae strains associated with endemic cholera (n = 32), including strains (n = 3) from surface water sources, in Khon Kaen, Thailand (2003-2011), were subjected to microbiological, molecular and phylogenetic analyses. According to phenotypic and related genetic data, all tested V. cholerae strains belonged to serogroup O1, biotype El Tor (ET), Inaba (IN) or Ogawa (OG). All of the strains were sensitive to gentamicin and ciprofloxacin, while multidrug-resistant (MDR) strains showing resistance to erythromycin, tetracycline, trimethoprim/sulfamethoxazole and ampicillin were predominant in 2007. V. cholerae strains isolated before and after 2007 were non-MDR. All except six diarrhoeal strains possessed ctxA and ctxB genes and were toxigenic altered ET, confirmed by MAMA-PCR and DNA sequencing. Year-wise data revealed that V. cholerae INET strains isolated between 2003 and 2004, plus one strain isolated in 2007, lacked the RS1 sequence (rstC) and toxin-linked cryptic plasmid (TLC)-specific genetic marker, but possessed CTX(CL) prophage genes ctxB(CL) and rstR(CL). A sharp genetic transition was noted, namely the majority of V. cholerae strains in 2007 and all in 2010 and 2011 were not repressor genotype rstR(CL) but instead were rstR(ET), and all ctx(+) strains possessed RS1 and TLC-specific genetic markers. DNA sequencing data revealed that strains isolated since 2007 had a mutation in the tcpA gene at amino acid position 64 (N→S). Four clonal types, mostly of environmental origin, including subtypes, reflected genetic diversity, while distinct signatures were observed for clonally related, altered ET from Thailand, Vietnam and Bangladesh, confirmed by distinct subclustering patterns observed in the PFGE (NotI)-based dendrogram, suggesting that endemic cholera is caused by V. cholerae indigenous to Khon Kaen.


Subject(s)
Cholera/epidemiology , Cholera/microbiology , Endemic Diseases , Vibrio cholerae/drug effects , Vibrio cholerae/genetics , Anti-Bacterial Agents/pharmacology , Cholera Toxin/genetics , Cluster Analysis , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , Drug Resistance, Bacterial , Genetic Variation , Genotype , Humans , Microbial Sensitivity Tests , Molecular Epidemiology , Molecular Typing , Plasmids , Polymerase Chain Reaction , Prophages/genetics , Sequence Analysis, DNA , Serotyping , Thailand/epidemiology , Vibrio cholerae/classification , Vibrio cholerae/isolation & purification , Virulence Factors/genetics , Water Microbiology
5.
J Med Microbiol ; 61(Pt 12): 1736-1745, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22977073

ABSTRACT

Vibrio cholerae O1 biotype El Tor (ET), causing the seventh cholera pandemic, was recently replaced in Bangladesh by an altered ET possessing ctxB of the Classical (CL) biotype, which caused the first six cholera pandemics. In the present study, V. cholerae O1 strains associated with endemic cholera in Dhaka between 2006 and 2011 were analysed for major phenotypic and genetic characteristics. Of 54 representative V. cholerae isolates tested, all were phenotypically ET and showed uniform resistance to trimethoprim/sulfamethoxazole (SXT) and furazolidone (FR). Resistance to tetracycline (TE) and erythromycin (E) showed temporal fluctuation, varying from year to year, while all isolates were susceptible to gentamicin (CN) and ciprofloxacin (CIP). Year-wise data revealed erythromycin resistance to be 33.3 % in 2006 and 11 % in 2011, while tetracycline resistance accounted for 33, 78, 0, 100 and 27 % in 2006, 2007, 2008, 2009 and 2010, respectively; interestingly, all isolates tested were sensitive to TE in 2011, as observed in 2008. All V. cholerae isolates tested possessed genetic elements such as SXT, ctxAB, tcpA(ET), rstR(ET) and rtxC; none had IntlI (Integron I). Double mismatch amplification mutation assay (DMAMA)-PCR followed by DNA sequencing and analysis of the ctxB gene revealed a point mutation at position 58 (C→A), which has resulted in an amino acid substitution from histidine (H) to asparagine (N) at position 20 (genotype 7) since 2008. Although the multi-resistant strains having tetracycline resistance showed minor genetic divergence, V. cholerae strains were clonal, as determined by a PFGE (NotI)-based dendrogram. This study shows 2008-2010 to be the time of transition from ctxB genotype 1 to genotype 7 in V. cholerae ET causing endemic cholera in Dhaka, Bangladesh.


Subject(s)
Anti-Bacterial Agents/pharmacology , Cholera/microbiology , Drug Resistance, Multiple, Bacterial/genetics , Endemic Diseases , Vibrio cholerae O1/genetics , beta-Lactamases/genetics , Amino Acid Sequence , Bacterial Typing Techniques , Bangladesh/epidemiology , Base Sequence , Cholera/drug therapy , Cholera/epidemiology , Ciprofloxacin/pharmacology , DNA, Bacterial/genetics , Erythromycin/pharmacology , Furazolidone/pharmacology , Genetic Variation , Gentamicins/pharmacology , Humans , Microbial Sensitivity Tests , Sequence Alignment , Sequence Analysis, DNA , Sulfamethoxazole/pharmacology , Tetracycline/pharmacology , Trimethoprim/pharmacology , Vibrio cholerae O1/classification , Vibrio cholerae O1/drug effects , Vibrio cholerae O1/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...